The Rap Game Star Nia Kay Releases New Single “Go Best Friend” And Named Ambassador For JDRF
New York, NY – (November 18th, 2021) – Chicago rapper and rising star, Nia Kay is set to release a new single titled, “Go Best Friend” on Friday, November 19. Nia releases this new single on the heels of the successful debut of the song “Ignored” which ranked #2 on the BET Jams Fresh Face Friday countdown. To date, Nia has collaborated with Asian Doll and received industry co-signs from Cardi B and Dreezy. She has also been featured in Vogue Italia, Wonderland Magazine, Untitled Magazine, LA Weekly, Sweety High, Hello Beautiful and other publications.
With more than 6.7 million fans on Facebook and 1.6 million followers on Instagram, Nia is excited to share “Go Best Friend” with her fanbase. The single will be released under Smash Town Records/Tha Branch.
“’Go Best Friend’ is about encouraging your bestie to have fun and live life to the fullest. There’s no limit when your bestie is by your side,” says Nia. “I also hope it inspires others who may be facing challenges that you have to remember to celebrate the wins and enjoy life.”
In addition to the release of “Go Best Friend,” Nia will be stepping up as an ambassador for JDRF, the leading global type 1 diabetes (T1D) non-profit. In this new role, she will be joining efforts with the organization to educate the public about T1D, and the importance of prescreening, which can help people avoid severe life-threatening conditions at the onset of the disease.
For Nia, this partnership is incredibly personal as she was diagnosed with T1D at the young age of three. Growing up with this life-threatening autoimmune disease has fueled her passion for raising awareness and encouraging others to live with the condition, that they too can achieve their dreams.
“We’re thrilled to partner with Nia. A Centers for Disease Control and Prevention (CDC) report focused on T1D in youth, showed that T1D is growing most sharply in African American and Hispanic youth populations,” said Kenya Felton, JDRF Senior Manager of PR and Celebrity Partnerships. “Nia’s voice is needed to break the stigma, reach diverse communities and help people better understand the disease.”
Nia and JDRF will launch a social media campaign in the coming months, to highlight her personal journey and showcase how she successfully balances a demanding work schedule, travel, and other activities while managing the disease. They will also collaborate to spread the word about the JDRF T1Detect screening education and awareness program designed to help people determine if they are at risk for developing T1D, which can ultimately save lives.
Press Release distributed in partnership with Rubenstein PR on behalf of Nia Kay
About Type 1 Diabetes (T1D)
T1D is a chronic, life-threatening autoimmune disease that can strike children and adults at any age. It requires rigorous 24/7 monitoring of blood glucose levels—even overnight—to avoid potentially lethal highs and lows in blood sugar, as well as other devastating complications like kidney, eye and nerve diseases. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset is sudden and is not related to diet or lifestyle. In T1D, the body’s immune system destroys cells in the pancreas that produce insulin, meaning the body produces little to no insulin to regulate blood sugar and get energy from food. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.
JDRF’s mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information,